Intra-Cellular Therapies Operating Income 2013-2024 | ITCI
Intra-Cellular Therapies operating income for the twelve months ending September 30, 2024 was $-0.122B, a 29.58% decline year-over-year.
- Intra-Cellular Therapies annual operating income for 2023 was $-0.159B, a 39.54% decline from 2022.
- Intra-Cellular Therapies annual operating income for 2022 was $-0.264B, a 7.72% decline from 2021.
- Intra-Cellular Therapies annual operating income for 2021 was $-0.286B, a 23.55% increase from 2020.